DalsnaFinance › IPOs › Summit Therapeutics › IPO
Summit Therapeutics Inc. completed its initial public offering on NASDAQ on March 5, 2015, pricing at $9.90 a share.
| Ticker | SMMT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 5, 2015 |
| Offering price | $9.90 |
| Shares offered | 3,450,000 |
| Total raised | $34M |
Summit Therapeutics Inc. sold 3,450,000 shares at $9.90 each on NASDAQ. Multiplied out, that is $34.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $34 million total recorded for the deal.
Summit Therapeutics Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Summit Therapeutics Inc.. This page is general information, not investment advice.